STERIS plc STE
208.93
0.16
0.08%
as of 25 Sep
- Market cap
- $20.4B
- P/E
- 25.4×
Follow STE
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
STERIS plc (STE) Debt to equity
STERIS plc's debt to equity at the end of the quarter to 30 June 2026 was 0.3×, down 0.0× from fiscal 2026 (0.3×). Over the past ten years it has ranged from 0.3× (fiscal 2026) to 0.6× (fiscal 2015) — the current reading is the lowest in ten years. That is above the Medical Devices industry median of 0.1× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Annual
| Period | Debt to equity | Change |
|---|---|---|
| FY2026 | 0.3× | (13.11%) |
| FY2025 | 0.3× | (39.16%) |
| FY2024 | 0.5× | 0.38% |
| FY2023 | 0.5× | 7.18% |
| FY2022 | 0.5× | 9.72% |
| FY2021 | 0.4× | 25.61% |
| FY2020 | 0.3× | (7.81%) |
| FY2019 | 0.4× | (9.19%) |
| FY2018 | 0.4× | (22.26%) |
| FY2017 | 0.5× | 1.98% |
Quarterly
| Period | Debt to equity | Change |
|---|---|---|
| Jun 2026 | 0.3× | (2.31%) |
| Mar 2026 | 0.3× | 1.36% |
| Dec 2025 | 0.3× | (2.00%) |
| Sep 2025 | 0.3× | (1.03%) |
| 42 more quarters | Free account |
Against its own ten years
Low 0.3×
High 0.6×
Ten-year median
0.5×
Current reading's percentile
8
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| PEN Penumbra, Inc. compare | 0.0× |
| BIO.B Bio-Rad Laboratories, Inc. compare | 0.2× |
| BIO Bio-Rad Laboratories, Inc. compare | 0.2× |
| STE STERIS plc | 0.3× |
| DXCM DexCom, Inc. compare | 0.5× |
| PHG Koninklijke Philips N.V. compare | 0.6× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 0.6× |
| SNN Smith & Nephew SNATS, Inc. compare | 0.6× |
| GEHC GE HealthCare Technologies Inc. compare | 1.0× |
| Medical Devices industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.2× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on STE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement